Impact of Intravenous Nitrate Treatment on Antiplatelet Effects of Clopidogrel in Acute Coronary Syndrome Patients: A Pilot Study
Background Clopidogrel is a pro-drug that requires metabolic activation by hepatic cytochrome P450 (CYP) enzymes in two steps. Previous studies have shown that the administration of continuous nitrate significantly affects the activity of hepatic CYP. In this pilot study, we assess the impact of int...
Saved in:
| Main Authors: | Mehmet Melek MD, Hasan Ari MD, Alper Karakuş MD, Selma Ari MD, Ahmet Tütüncü MD, Tahsin Bozat MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Journal of Cardiovascular Pharmacology and Therapeutics |
| Online Access: | https://doi.org/10.1177/10742484251357147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01) -
The impact of platelets and antiplatelets medications on immune mediation
by: Leela Morena, MD, et al.
Published: (2025-01-01) -
ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01) -
Intravenous iron reactions: Insights from an allergy and immunology perspective
by: Jordon Jaggers, MD, et al.
Published: (2025-11-01) -
THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)